8 matches for your search in the start-up spotlight
rssWe are a spin-out from the Technical University of Munich, specialising in the clinical and commercial development of a proprietary oncolytic virus platform for cancer immunotherapy. Fusix Biotech GmbH is a Munich based start-up founded in 2022. The management team is comprised of the four ...
Iguana Biotechnology GmbH (Iguana), an innovative BioTech start-up based in Munich, Germany, is pursuing as a lead candidate the development of a therapeutic vaccine against Helicobacter pylori, one of the most common infectious diseases worldwide. Currently, around 50% of the world's population ...
AATec Medical GmbH is a biotechnology company developing a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases, virus infections and rare diseases. The company has successfully demonstrated proof-of-principle in several indications and is ...
mbiomics is a pioneer in targeted microbiome profiling. Our patented precision technology enables unparalleled quantitative resolution and drastically faster microbiome analysis. This creates a basis for various future clinical applications and it will accelerate microbiome-based therapeutics ...
We prefer to enjoy the sea on the beach than on our plates. Our purely plant-based Happy Ocean prawns are not only delicious, but also healthy: for you and our oceans. Happy Ocean Foods was founded in 2020 by Julian Hallet and Robin Drummond. As passionate surfers who care about the ecological ...
Tubulis generates uniquely matched antibody-drug conjugates (ADCs) through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of protein-drug conjugates by increasing design flexibility while overcoming ...
NEUREVO is developing and will licence first-in-class neuroprotective treatments that effectively protect against multiple neurological disorders. This includes neurodegenerative diseases like ALS or Parkinson's disease and stroke. Our technology is based on the protection and enhancement of ...